|
1
|
Lowe JB: Glycan-dependent leukocyte
adhesion and recruitment in inflammation. Curr Opin Cell Biol.
15:531–538. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Springer TA: Traffic signals for
lymphocyte recirculation and leukocyte emigration: The multistep
paradigm. Cell. 76:301–314. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kannagi R: Molecular mechanism for
cancer-associated induction of sialyl Lewis X and sialyl Lewis A
expression-the Warburg effect revisited. Glycoconj J. 20:353–364.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Roseman S: Reflections on glycobiology. J
Biol Chem. 276:41527–41542. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu YC, Yen HY, Chen CY, Chen CH, Cheng
PF, Juan YH, Chen CH, Khoo KH, Yu CJ, Yang PC, et al: Sialylation
and fucosylation of epidermal growth factor receptor suppress its
dimerization and activation in lung cancer cells. Proc Natl Acad
Sci USA. 108:11332–11337. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kannagi R: Carbohydrate-mediated cell
adhesion involved in hematogenous metastasis of cancer. Glycoconj
J. 14:577–584. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Takada A, Ohmori K, Yoneda T, Tsuyuoka K,
Hasegawa A, Kiso M and Kannagi R: Contribution of carbohydrate
antigens sialyl Lewis A and sialyl Lewis X to adhesion of human
cancer cells to vascular endothelium. Cancer Res. 53:354–361.
1993.PubMed/NCBI
|
|
8
|
Ito H, Hiraiwa N, Sawada-Kasugai M,
Akamatsu S, Tachikawa T, Kasai Y, Akiyama S, Ito K, Takagi H and
Kannagi R: Altered mRNA expression of specific molecular species of
fucosyl- and sialyltransferases in human colorectal cancer tissues.
Int J Cancer. 71:5560–5564. 1997. View Article : Google Scholar
|
|
9
|
Ogawa JI, Inoue H and Koide S:
α-2,3-Sialyltransferase type 3N and α-1,3-fucosyltransferase type
VII are related to sialyl Lewis x synthesis and patient survival
from lung carcinoma. Cancer. 79:1678–1685. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kuijipers TW: Terminal glycosyltransferase
activity: A selective role in cell adhesion. Blood. 81:873–882.
1993.
|
|
11
|
Candelier JJ, Mollicone R, Mennesson B,
Bergemer AM, Henry S, Couillin P and Oriol R:
Alpha-3-fucosyltransferases and their glycoconjugate antigen
products in the developing human kidney. Lab Invest. 69:449–459.
1993.PubMed/NCBI
|
|
12
|
Stroup GB, Anumula KR, Kline TF and
Caltabiano MM: Identification and characterization of two distinct
a-1-3-L-fucosyltransferase activities in human colon carcinoma.
Cancer Res. 50:6787–6792. 1990.PubMed/NCBI
|
|
13
|
Mollicone R, Candelier JJ, Mennesson B,
Couillin P, Venot AP and Oriol R: Five specificity patterns of
(1→3)-α-L-fucosyltransferase activity defined by use of synthetic
oligosaccharide acceptors. Differential expression of the enzymes
during human embryonic development and in adult tissues. Carbohydr
Res. 228:265–276. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Macher BA, Holmes EH, Swiedler SJ, Stults
CM and Srnka CA: Human alpha 1-3 fucosyltransferases. Glycobiology.
6:577–584. 1991. View Article : Google Scholar
|
|
15
|
Kukowska-Latallo JF, Larsen RD, Nair RP
and Lowe JB: A cloned human cDNA determines expression of a mouse
stage-specific embryonic antigen and the Lewis blood group alpha
(1,3/1,4) fucosyltransferase. Genes Dev. 4:1288–1303. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Goelz SE, Hession C, Goff D, Griffiths B,
Tizaed R, Newman B, Chi-Rosso G and Lobb R: ELFT: A gene that
directs the expression of an ELAM-1 ligand. Cell. 63:1349–1356.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lowe JB, Kukowska-Latallo JF, Nair RP,
Larsen RD, Marks RM, Macher BA, Kelly R and Ernst LK: Molecular
cloning of a human fucosyltransferase gene that determines
expression of the Lewis x and VIM-2 epitopes but not
ELAM-1-dependent cell adhesion. J Biol Chem. 266:17467–17477.
1991.PubMed/NCBI
|
|
18
|
Kumar R, Potvin B, Muller WA and Stanley
P: Cloning of a human alpha(1,3)-fucosyltransferase gene that
encodes ELFT but does not confer ELAM-1 recognition on Chinese
hamster ovary cell transfectants. J Biol Chem. 266:21777–21783.
1991.PubMed/NCBI
|
|
19
|
Weston BW, Nair RP, Larsen RD and Lowe JB:
Isolation of a novel human alpha (1,3)fucosyltransferase gene and
molecular comparison to the human Lewis blood group alpha (1,3/1,4)
fucosyltransferase gene. Syntenic, homologous, nonallelic genes
encoding enzymes with distinct acceptor substrate specificities. J
Biol Chem. 267:4152–4160. 1992.PubMed/NCBI
|
|
20
|
Weston BW, Smith PL, Kelly RJ and Lowe JB:
Molecular cloning of a fourth member of a human alpha (1,3)
fucosyltransferase gene family Multiple homologous sequences that
determine expression of the Lewis x, sialyl Lewis x, and difucosyl
sialyl Lewis x epitopes. J Biol Chem. 267:24575–24584.
1992.PubMed/NCBI
|
|
21
|
Koszdin KL and Bowen BR: The cloning and
expression of a human alpha-1,3 fucosyltransferase capable of
forming the E-selectin ligand. Biochem Biophys Res Commun.
187:152–157. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sasaki K, Kurata K, Funayama K, Nagata M,
Watanabe E, Ohta S, Hanai N and Nishi T: Expression cloning of a
novel alpha 1,3-fucosyltransferase that is involved in biosynthesis
of the sialyl Lewis x carbohydrate determinants in leukocytes. J
Biol Chem. 269:14730–14737. 1994.PubMed/NCBI
|
|
23
|
Natsuka S, Gersten KM, Zenita K, Kannagi R
and Lowe JB: Molecular cloning of a cDNA encoding a novel human
leukocyte alpha-1,3-fucosyltransferase capable of synthesizing the
sialyl Lewis x determinant. J Biol Chem. 269:16789–16794.
1994.PubMed/NCBI
|
|
24
|
Kudo K, Ikehara Y, Togayachi A, Kaneko M,
Hiraga T, Sasaki K and Narimatsu H: Expression, cloning and
characterization of a novel murine alpha1,3-fucosyltransferase,
mFuc-IX, that synthesis the Lewis X (CD15) epitope in brain and
kidney. J Biol Chem. 273:26729–26738. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Narimatsu H: Human fucosyltransferases:
Tissue distribution of blood group antigens, cancer associated
antigens and fucosyltransferase. Tanpakushitsu Kakusan Koso.
43(Suppl 16): S2394–S2403. 1998.In Japanese.
|
|
26
|
Albrethsen J, Bøgebo R, Gammeltoft S,
Olsen J, Winther B and Raskov H: Upregulated expression of human
neutrophil peptides 12 and 3 (HNP13) in colon cancer serum and
tumours: A biomarker study. BMC Cancer. 5:82005. View Article : Google Scholar
|
|
27
|
Hiller KM, Mayben JP, Bendt KM, Manousos
GA, Senqer K, Cameron HS and Weston BW: Transfection of alpha (1,3)
fucosyltransferase antisense sequences impairs the proliferative
and tumorigenic ability of human colon carcinoma cells. Mol
Carcinog. 27:280–288. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods.
25:402–408. 2001. View Article : Google Scholar
|
|
29
|
Cordeiro C and Freire AP: Digiton in
permeabilization of Saccharomyces cerevisiae cells for in situ
enzyme assay. Anal Biochem. 229:145–148. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Berridge MJ: Inositol triphosphate and
diacylycerol as second messenger. Biochem J. 220:345–360. 1984.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Klinger M, Farhan H, Just H, Drobny H,
Himmler G, Loibner H, Mudde GC, Freissmuth M and Sexl V: Antibodies
directed against Lewis -Y antigen inhibit signaling of Lewis-Y
modified ErbB receptors. Cancer Res. 64:1087–1093. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Farhan H, Schuster C, Klinger M, Weisz E,
Waxenecker G, Schuster M, Sexl V, Mudde GC, Freissmuth M and
Kircheis R: Inhibition of xenograft tumor growth and
down-regulation of ErbB receptors by an antibody directed against
Lewis Y antigen. J Pharmacol Exp Ther. 319:1459–1466. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Scott AM, Geleick D, Rubira M, Clarke K,
Nice EC, Smyth FE, Stockert E, Richards EC, Carr FJ, Harris WJ, et
al: Construction, production, and characterization of humanized
anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy
of solid tumors. Cancer Res. 60:3254–3261. 2000.PubMed/NCBI
|
|
34
|
Kannagi R: Carbohydrate antigen sialyl
Lewis a-its pathophysiological significance and induction mechanism
in cancer progression. Chang Gung Med J. 30:189–209.
2007.PubMed/NCBI
|
|
35
|
Kannagi R, Izawa M, Koike T, Miyazaki K
and Kimura N: Carbohydrate-mediated cell adhesion in cancer
metastasis and angiogenesis. Cancer Sci. 95:377–384. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sakai N, Okada Y and Tsuji T: Increased
serum levels of the carrier molecules of the carbohydrate antigen
sialyl Lewis X in liver diseases. Acta Med Okayama. 51:79–85.
1997.PubMed/NCBI
|
|
37
|
Fujiwara Y, Shimada M, Takenaka K,
Kajiyama K, Shirabe K and Sugimachi K: The Sialyl Lewis X
expression in hepatocarcinogenesis: Potential predictor for the
emergence of hepatocellular carcinoma. Hepatogastroenterology.
49:213–217. 2002.PubMed/NCBI
|
|
38
|
Okada Y, Jin-no K, Ikeda H, Sakai N,
Sotozono M, Yonei T, Nakanishi S, Moriwaki S and Tsuji T: Changes
in the expression of sialyl-Lewisx, a hepatic
necroinflammation-associated carbohydrate neoantigen, in human
hepatocellular carcinomas. Cancer. 73:1811–1816. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Torii A, Nakayama A, Harada A, Nakao A,
Nonami T, Sakamoto J, Watanabe T, Ito M and Takagi H: Expression of
the CD15 antigen in hepatocellular carcinoma. Cancer. 71:3864–3867.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kang X, Wang N, Pei C, Sun L, Sun R, Chen
J and Liu Y: Glycan-related gene expression signatures in human
metastatic hepatocellular carcinoma cells. Exp Ther Med. 3:415–422.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Delmas P, Crest M and Brown DA: Functional
organization of PLC signaling microdomains in neurons. Trends
Neurosci. 27:41–47. 2004. View Article : Google Scholar
|
|
42
|
Liu B and Wu D: Analysis of G
protein-mediated activation of phospholipase C in cultured cells.
Methods Mol Biol. 237:99–102. 2004.
|
